178 related articles for article (PubMed ID: 22080892)
21. Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.
Klar M; Hasenburg A; Hasanov M; Hilpert F; Meier W; Pfisterer J; Pujade-Lauraine E; Herrstedt J; Reuss A; du Bois A
Eur J Cancer; 2016 Oct; 66():114-24. PubMed ID: 27561452
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis.
Wang Y; Wang D; Ren M
Tumour Biol; 2014 Jan; 35(1):33-8. PubMed ID: 23873100
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of epithelial ovarian cancer.
Webb PM; Jordan SJ
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():3-14. PubMed ID: 27743768
[TBL] [Abstract][Full Text] [Related]
24. Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival.
Dixon SC; Ibiebele TI; Protani MM; Beesley J; deFazio A; Crandon AJ; Gard GB; Rome RM; Webb PM; Nagle CM;
Gynecol Oncol; 2014 Mar; 132(3):566-72. PubMed ID: 24368279
[TBL] [Abstract][Full Text] [Related]
25. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
[TBL] [Abstract][Full Text] [Related]
26. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis.
Fu Z; Taylor S; Modugno F
Gynecol Oncol; 2022 Jun; 165(3):650-663. PubMed ID: 35473671
[TBL] [Abstract][Full Text] [Related]
27. Central nervous system metastases from epithelial ovarian cancer: prognostic factors and outcomes.
Cormio G; Loizzi V; Falagario M; Calace A; Colamaria A; De Tommasi A; Selvaggi LE
Int J Gynecol Cancer; 2011 Jul; 21(5):816-21. PubMed ID: 21613959
[TBL] [Abstract][Full Text] [Related]
28. Obesity-associated adipokines correlate with survival in epithelial ovarian cancer.
Diaz ES; Karlan BY; Li AJ
Gynecol Oncol; 2013 May; 129(2):353-7. PubMed ID: 23402904
[TBL] [Abstract][Full Text] [Related]
29. The influence of comorbidity on mortality in ovarian cancer patients.
Stålberg K; Svensson T; Lönn S; Kieler H
Gynecol Oncol; 2014 May; 133(2):298-303. PubMed ID: 24582801
[TBL] [Abstract][Full Text] [Related]
30. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
31. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium.
Minlikeeva AN; Cannioto R; Jensen A; Kjaer SK; Jordan SJ; Diergaarde B; Szender JB; Odunsi K; Almohanna H; Mayor P; Starbuck K; Zsiros E; Bandera EV; Cramer DW; Doherty JA; DeFazio A; ; Edwards R; Goode EL; Goodman MT; Høgdall E; Matsuo K; Mizuno M; Nagle CM; Ness RB; Paddock LE; Pearce CL; Risch HA; Rossing MA; Terry KL; Wu AH; Modugno F; Webb PM; Moysich KB;
Cancer Causes Control; 2019 May; 30(5):537-547. PubMed ID: 30905014
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy for Patients with advanced epithelial ovarian cancer: A Meta-Analysis.
Zeng LJ; Xiang CL; Gong YZ; Kuang Y; Lu FF; Yi SY; Zhang Y; Liao M
Sci Rep; 2016 Nov; 6():35914. PubMed ID: 27804983
[TBL] [Abstract][Full Text] [Related]
33. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.
Wang KC; Chang WH; Lee WL; Huang N; Huang HY; Yen MS; Guo CY; Wang PH
BMC Cancer; 2014 Nov; 14():831. PubMed ID: 25403543
[TBL] [Abstract][Full Text] [Related]
34. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
36. Tea consumption and epithelial ovarian cancer risk: a systematic review of observational studies.
Oppeneer SJ; Robien K
Nutr Cancer; 2011; 63(6):817-26. PubMed ID: 21800977
[TBL] [Abstract][Full Text] [Related]
37. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
38. Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group.
Altman AD; Lambert P; Love AJ; Turner D; Lotocki R; Dean E; Popowich S; Nachtigal MW
Int J Gynecol Cancer; 2017 Oct; 27(8):1637-1644. PubMed ID: 28704327
[TBL] [Abstract][Full Text] [Related]
39. Endometriosis and the subsequent risk of epithelial ovarian cancer.
Chang WH; Wang KC; Lee WL; Huang N; Chou YJ; Feng RC; Yen MS; Huang BS; Guo CY; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):530-5. PubMed ID: 25510696
[TBL] [Abstract][Full Text] [Related]
40. Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?
Lydiksen L; Jensen-Fangel S; Blaakaer J
Gynecol Oncol; 2014 Jun; 133(3):454-9. PubMed ID: 24726613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
